caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1598734261

Bhaskar RoyM.D.

PRACTICETEXAS ENDOCRINE & DIABETES INSTITUTESee all providers at this practice →
EndocrinologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
214
Unique beneficiaries
—
Total services
477
Distinct HCPCS
2
Medicare payment
$38K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 484 Endocrinology providers in TX — below median (cohort median 868).
REFERRAL NETWORK

Where Bhaskar Roy's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
3771,272
Nowice Trexler
Diagnostic Radiology · Houston, TX
2147
METHODIST HEALTH CENTERS1627
Sherif Khalil
Ophthalmology · Houston, TX
1329
Stephen Parven
Diagnostic Radiology · Houston, TX
1336
Stanley Lim
Diagnostic Radiology · Houston, TX
1221
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER1128
Alan Jarrett
Ophthalmology · Houston, TX
1128
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
4,121
Beneficiaries
—
Total drug cost
$1.0M
Distinct drugs
63
Brand share
41.6%
Top prescribed drugs
Levothyroxine Sodium544 claims
Metformin Hcl248 claims
Semaglutide221 claims
Atorvastatin Calcium216 claims
Amlodipine Besylate199 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.